An infamous big pharma company has been covering up SIDS (sudden infant death syndrome) by distributing suspicious vaccine lots all over the country. Wyeth Laboratories, which attempted to hide the clusters of SIDS deaths was bought by Pfizer in 2009.
Pfizer is notorious for shady business practices and using harsh language to panic people into using their products.
Pfizer CEO: If You Dislike My Product, You’re A Criminal
This document should be considered a substantial precedent in knowing just how far these corporations are willing to go in attempts to cover up and obfuscate the harm their products can cause:
According to Inversionism on Substack, the harm was numerous cases of SIDS that happened in a cluster in Tennessee after the use of the DTP vaccine made by Wyeth in the 1970s. The DPT vaccine or DTP vaccine is a class of combination vaccines that allegedly protects humans against three infectious diseases: diphtheria, pertussis, and tetanus.
Wyeth went to great lengths to cover up SIDS by changing their policies on how vaccine lots are distributed to doctor practices to be administered. Normally they would just send vaccines out by the batch, but after the SIDS clusters were reported, they started splitting up the batches and sending them to many different parts of the country so it was much more difficult for people to make connections between SIDS or other adverse events and the injection of Wyeth’s vaccines. They continued this practice of mixing batches going forward, so who knows how many more adverse reactions or deaths were caused by their vaccines that were left unknown or ignored.
Wyeth was never held accountable for these crimes against humanity and the subsequent cover-up. Instead, they were bought by another repeated criminal corporation called Pfizer in 2009 for $68 billion.
Pfizer Employees Received “Special Batches” of COVID Jabs
Get Your Annual COVID Booster: FDA Expected To Approve Pfizer’s New Shot
Pfizer has been known to be disingenuous and hide information that’s critical to the public.
Comments